Company / Operating Income per Share
ArriVent BioPharma, Inc. Operating Income per Share History
FY2023-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$3.00
FY2024
5-year range
-$34.84 / -$3.00
FY2023-FY2024
Trend
+91.4%
vs FY2023
Sector context
#140 of 201
Health Care
What the data says
At $-3.00, ArriVent BioPharma, Inc.'s operating income per share ranks #140 of 201 in the Health Care sector.
Based on SEC 10-K filings.
-3.00 in FY2024.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#140 of 201 in Health CareTop 70% of 201This company -$3.00 Sector average -$28.56
▼
+89.5% above sector average
Key checks
Key Insights
- In FY2024, operating income per share increased 91.4% year-over-year.
- Ranks #140 out of 201 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$3.00 | +91.4% |
| FY2023 | -$34.84 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026